Abstract
Krennmair G, Seemann R, Piehslinger E. Dental implants in patients with rheumatoid arthritis: clinical outcome and peri‐implant findings. J Clin Periodontol 2010; 37: 928–936. doi: 10.1111/j.1600‐051X.2010.01606.x. Purpose: Implant prosthodontic treatment outcomes for patients suffering from autoimmune rheumatoid arthritis (RA) with or without concomitant connective tissue diseases (CTD) were evaluated.Material and Methods: Thirty‐four female patients' (25 isolated RA; nine RA+CTD) implant survival/success rate, peri‐implant conditions (marginal bone loss, pocket depth, plaque index, gingiva index and bleeding index) and incidence of prosthodontic maintenance were retrospectively evaluated.Results: Implants evaluated presented a high implant survival (100%) and a 3.5‐year success (93.8%) rate during the follow‐up programme (mean 47.6 month) without difference between isolated RA (94.6%) and RA and concomitant CTD (92.3%), respectively. In isolated RA, acceptable marginal bone resorption (mean: 2.1 mm; SD: 0.5 mm), pocket depth (mean: 2.8 mm; SD:3.2 mm) and healthy soft‐tissue conditions (plaque/bleeding/gingiva index Grade 0 in 80%) were noticed. However, patients with RA+CTD presented increased bone resorption (mean: 3.1 mm; SD: 0.7 mm) and more vulnerable soft‐tissue conditions (higher bleeding index) differing significantly to patients with isolated RA (pConclusions: In contrast to isolated RA, in RA patients with concomitant CTD, differences in the peri‐implant parameters such as pronounced marginal bone resorption and bleeding may be anticipated and appear to be significantly influenced by the patients' underlying disease.

This publication has 41 references indexed in Scilit: